Jan G. J. van de Winkel, Ph.D of @Genmab announces data to be presented at ASH 2019 including data from ongoing phase I DuoBody®-CD3xCD20 (GEN3013) trial.
Genmab Announces Data to be Presented at #ASH19 @Genmab
Jan G. J. van de Winkel, Ph.D of @Genmab announces data to be presented at ASH 2019 including data from ongoing phase I DuoBody®-CD3xCD20 (GEN3013) trial.